Khiron Life Sciences Corp.: Invitation to the Q3 Virtual Investor Summit

Toronto, Ontario--(Newsfile Corp. - August 11, 2021) - Khiron Life Sciences Corp. (TSXV: KHRN) today announced that Alvaro Torres will be attending the Q3 Virtual Investor Summit.

About Khiron Life Sciences Corp.

Khiron is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health centres and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico in 2021. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.

For further information:

Khiron Life Sciences Corp.
Paola Ricardo
+1 (647) 556-5750
investors@khiron.ca

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration, please click here: Complimentary Investor Registration

Contact:

Sasha Murray at sasha@investorsummitgroup.com